Compare CALM & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CALM | OGN |
|---|---|---|
| Founded | 1957 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.6B |
| IPO Year | 1996 | 2020 |
| Metric | CALM | OGN |
|---|---|---|
| Price | $69.87 | $13.91 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $68.33 | $10.33 |
| AVG Volume (30 Days) | 833.8K | ★ 2.3M |
| Earning Date | 01-06-2027 | 10-30-2026 |
| Dividend Yield | ★ 1.53% | 0.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.56 |
| Revenue | $2,911,632,000.00 | ★ $6,216,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.37 | $2.07 |
| P/E Ratio | ★ N/A | $8.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $60.13 | $5.69 |
| 52 Week High | $95.25 | $13.91 |
| Indicator | CALM | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 58.21 | 65.68 |
| Support Level | $60.91 | $13.74 |
| Resistance Level | $80.00 | N/A |
| Average True Range (ATR) | 2.82 | 0.04 |
| MACD | 0.65 | 0.00 |
| Stochastic Oscillator | 80.38 | 86.11 |
Cal-Maine Foods Inc is an egg company in the U.S. Its shell egg portfolio includes conventional, specialty, cage-free, nutritionally enhanced, organic, brown, pasture-raised, and free-range eggs. The Company operates through the Conventional Shell Eggs, Specialty Shell Eggs and Prepared Foods segments, with Conventional Shell Eggs generating maximum revenue. The Conventional Shell Eggs segment consists mainly of the production, grading, packaging, marketing and distribution of conventional shell eggs, including Sunups and Sunny Meadow. The Company sells its products to grocery store chains, club stores, independent supermarkets, and foodservice distributors serving restaurants, convenience stores, healthcare and education facilities, and hotels throughout the U.S.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.